CLINICAL_TRIALS
trial_result
· 2022-01-26
Clinical Trial Update: A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 [Phase 1]
Summary
Phase 1 study assessing injection pain and local tolerability after subcutaneous administration of TV-46046 in contraception.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Contraception | Phase 1 | Status: COMPLETED | Results posted: 2022-01-26